Factors affecting low fetal fraction in fetal screening with cell-free DNA in pregnant women: a systematic review and meta-analysis

Abstract Background Cell-Free DNA (cfDNA) is a non-invasive perinatal test (NIPT) used to assess fetal anomalies. The ability to detect fetal chromosomal aneuploidies is directly related to a sample’s fetal to total DNA fraction, known as the fetal fraction (FF). The minimum FF is considered 4%, and...

Full description

Bibliographic Details
Main Authors: Sanaz Mousavi, Ziba Shokri, Parvin Bastani, Morteza Ghojazadeh, Sevda Riahifar, Hooman Nateghian
Format: Article
Language:English
Published: BMC 2022-12-01
Series:BMC Pregnancy and Childbirth
Subjects:
Online Access:https://doi.org/10.1186/s12884-022-05224-7
_version_ 1811188717680852992
author Sanaz Mousavi
Ziba Shokri
Parvin Bastani
Morteza Ghojazadeh
Sevda Riahifar
Hooman Nateghian
author_facet Sanaz Mousavi
Ziba Shokri
Parvin Bastani
Morteza Ghojazadeh
Sevda Riahifar
Hooman Nateghian
author_sort Sanaz Mousavi
collection DOAJ
description Abstract Background Cell-Free DNA (cfDNA) is a non-invasive perinatal test (NIPT) used to assess fetal anomalies. The ability to detect fetal chromosomal aneuploidies is directly related to a sample’s fetal to total DNA fraction, known as the fetal fraction (FF). The minimum FF is considered 4%, and the test result below 4% is uncertain due to low fetal fraction (LFF). This study aimed to conduct a systematic review and a meta-analysis to determine the possible factors affecting LFF in cfDNA testing for fetal screening. Methods PubMed, Web of Science, Google Scholar, Since Direct, Scopus, CINHAL, Cochrane Library, and Persian databases, including Scientific Information Database, Irandoc, and Magiran were searched for studies investigating factors affecting LFF in cfDNA testing from 2000 until the end of 2021. Gathered data were analyzed using Comprehensive Meta-Analysis (CMA) software version 3.3.070. The quality of the included studies was assessed using the Joanna Briggs Institute Critical Appraisal of Cohort Studies tool. Results Thirteen articles related to the topic were included, and seven related articles were reviewed for meta-analysis. The other six were reviewed qualitatively. Four factors were identified that might have a potential effect on the LFF, of which only gestational age had a significant association with LFF (Pooled mean difference= -1.111, SE = 0.515, 95% CI= -2.121, -0.101, (P-value < 0.05)). Maternal age (P-value = 0.573), maternal weight (P-value = 0.113), and Body Mass Index (P-value = 0.104) had no statically significant effect. The effect size was pooled by mean difference and 95% confidence interval. Conclusion Lower gestational age is significantly associated with LFF. Thus, this factor can be considered when interpreting prenatal cfDNA screening tests.
first_indexed 2024-04-11T14:23:16Z
format Article
id doaj.art-544bc0571a6c4c8a9d9054605eca2f40
institution Directory Open Access Journal
issn 1471-2393
language English
last_indexed 2024-04-11T14:23:16Z
publishDate 2022-12-01
publisher BMC
record_format Article
series BMC Pregnancy and Childbirth
spelling doaj.art-544bc0571a6c4c8a9d9054605eca2f402022-12-22T04:18:57ZengBMCBMC Pregnancy and Childbirth1471-23932022-12-0122111110.1186/s12884-022-05224-7Factors affecting low fetal fraction in fetal screening with cell-free DNA in pregnant women: a systematic review and meta-analysisSanaz Mousavi0Ziba Shokri1Parvin Bastani2Morteza Ghojazadeh3Sevda Riahifar4Hooman Nateghian5Department of Gynecology and Obstetrics, Al-Zahra Hospital, Faculty of Medicine, Tabriz University of Medical SciencesDepartment of Gynecology and Obstetrics, Al-Zahra Hospital, Faculty of Medicine, Tabriz University of Medical SciencesDepartment of Gynecology and Obstetrics, Al-Zahra Hospital, Faculty of Medicine, Tabriz University of Medical SciencesResearch Center for Evidence‑Based Medicine, Iranian EBM Centre: A Joanna Briggs Institute Affiliated Group, Tabriz University of Medical SciencesDepartment of Biostatistics, Faculty of Public Health, Iran University of Medical SciencesResearch Center for Evidence‑Based Medicine, Iranian EBM Centre: A Joanna Briggs Institute Affiliated Group, Tabriz University of Medical SciencesAbstract Background Cell-Free DNA (cfDNA) is a non-invasive perinatal test (NIPT) used to assess fetal anomalies. The ability to detect fetal chromosomal aneuploidies is directly related to a sample’s fetal to total DNA fraction, known as the fetal fraction (FF). The minimum FF is considered 4%, and the test result below 4% is uncertain due to low fetal fraction (LFF). This study aimed to conduct a systematic review and a meta-analysis to determine the possible factors affecting LFF in cfDNA testing for fetal screening. Methods PubMed, Web of Science, Google Scholar, Since Direct, Scopus, CINHAL, Cochrane Library, and Persian databases, including Scientific Information Database, Irandoc, and Magiran were searched for studies investigating factors affecting LFF in cfDNA testing from 2000 until the end of 2021. Gathered data were analyzed using Comprehensive Meta-Analysis (CMA) software version 3.3.070. The quality of the included studies was assessed using the Joanna Briggs Institute Critical Appraisal of Cohort Studies tool. Results Thirteen articles related to the topic were included, and seven related articles were reviewed for meta-analysis. The other six were reviewed qualitatively. Four factors were identified that might have a potential effect on the LFF, of which only gestational age had a significant association with LFF (Pooled mean difference= -1.111, SE = 0.515, 95% CI= -2.121, -0.101, (P-value < 0.05)). Maternal age (P-value = 0.573), maternal weight (P-value = 0.113), and Body Mass Index (P-value = 0.104) had no statically significant effect. The effect size was pooled by mean difference and 95% confidence interval. Conclusion Lower gestational age is significantly associated with LFF. Thus, this factor can be considered when interpreting prenatal cfDNA screening tests.https://doi.org/10.1186/s12884-022-05224-7Low fetal fractionCell-free DNAFetal soft markerFetal screening
spellingShingle Sanaz Mousavi
Ziba Shokri
Parvin Bastani
Morteza Ghojazadeh
Sevda Riahifar
Hooman Nateghian
Factors affecting low fetal fraction in fetal screening with cell-free DNA in pregnant women: a systematic review and meta-analysis
BMC Pregnancy and Childbirth
Low fetal fraction
Cell-free DNA
Fetal soft marker
Fetal screening
title Factors affecting low fetal fraction in fetal screening with cell-free DNA in pregnant women: a systematic review and meta-analysis
title_full Factors affecting low fetal fraction in fetal screening with cell-free DNA in pregnant women: a systematic review and meta-analysis
title_fullStr Factors affecting low fetal fraction in fetal screening with cell-free DNA in pregnant women: a systematic review and meta-analysis
title_full_unstemmed Factors affecting low fetal fraction in fetal screening with cell-free DNA in pregnant women: a systematic review and meta-analysis
title_short Factors affecting low fetal fraction in fetal screening with cell-free DNA in pregnant women: a systematic review and meta-analysis
title_sort factors affecting low fetal fraction in fetal screening with cell free dna in pregnant women a systematic review and meta analysis
topic Low fetal fraction
Cell-free DNA
Fetal soft marker
Fetal screening
url https://doi.org/10.1186/s12884-022-05224-7
work_keys_str_mv AT sanazmousavi factorsaffectinglowfetalfractioninfetalscreeningwithcellfreednainpregnantwomenasystematicreviewandmetaanalysis
AT zibashokri factorsaffectinglowfetalfractioninfetalscreeningwithcellfreednainpregnantwomenasystematicreviewandmetaanalysis
AT parvinbastani factorsaffectinglowfetalfractioninfetalscreeningwithcellfreednainpregnantwomenasystematicreviewandmetaanalysis
AT mortezaghojazadeh factorsaffectinglowfetalfractioninfetalscreeningwithcellfreednainpregnantwomenasystematicreviewandmetaanalysis
AT sevdariahifar factorsaffectinglowfetalfractioninfetalscreeningwithcellfreednainpregnantwomenasystematicreviewandmetaanalysis
AT hoomannateghian factorsaffectinglowfetalfractioninfetalscreeningwithcellfreednainpregnantwomenasystematicreviewandmetaanalysis